Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles.
In conclusion, our results reveal that CNMs target the HIF-1α/VEGF pathway, which may be an important reason for the suppression of retinoblastoma growth and angiogenesis.
PMID: 32091275 [PubMed - in process]
Source: Drug Delivery - Category: Drugs & Pharmacology Tags: Drug Deliv Source Type: research
More News: China Health | Complementary Medicine | Drugs & Pharmacology | Eye Cancers | Herbs | Nanotechnology | Retinoblastoma